Home The Word Brain	My Amedeo FAQ Privacy About
	CC Journal Club Our weekly journal club for junior residents and medical students

Ophthalmology

Free Subscription Articles published in Surv Ophthalmol Retrieve available abstracts of 121 articles: HTML format

Single Articles

May 2025
1. SADEGHI E, Colorado-Zavala MF, Almuhtaseb H, Venkatesh R, et al
   Anatomical and functional changes after internal limiting membrane peeling.
   Surv Ophthalmol. 2025;70:357-368.
   PubMed     Abstract available
   
   
   
2. CHOPRA P, Fatima A, Mohapatra S, Murugaiyan K, et al
   Extracellular vesicles in dry eye disease and Sjogren's syndrome: A systematic review on their diagnostic and therapeutic role.
   Surv Ophthalmol. 2025;70:499-515.
   PubMed     Abstract available
   
   
   April 2025
3. UCAR F
   Comment on: "Postoperative complications of intrascleral intraocular lens fixation: A systematic review and meta-analysis".
   Surv Ophthalmol. 2025 Apr 3:S0039-6257(25)00065.
   PubMed    
   
   
   March 2025
4. MASTROGIUSEPPE E, Alisi L, Romaniello A, Caterino L, et al
   Managing Cutibacterium acnes endophthalmitis after cataract surgery: A systematic review and meta-analysis.
   Surv Ophthalmol. 2025 Mar 29:S0039-6257(25)00061.
   PubMed     Abstract available
   
   
   
5. AGARWAL A, Vempuluru VS, Kaliki S
   Primary Ocular, Adnexal, and Orbital Rhabdomyosarcoma: A Review.
   Surv Ophthalmol. 2025 Mar 27:S0039-6257(25)00060.
   PubMed     Abstract available
   
   
   
6. HUNG JH, Jain T, Khatri A, Nguyen TB, et al
   Inherited retinal diseases-associated uveitis.
   Surv Ophthalmol. 2025 Mar 27:S0039-6257(25)00057.
   PubMed     Abstract available
   
   
   
7. SHAIKH N, Kumawat D, Chandra P, Senthil S, et al
   Glaucoma in retinopathy of prematurity - A review.
   Surv Ophthalmol. 2025 Mar 25:S0039-6257(25)00056.
   PubMed     Abstract available
   
   
   
8. SIT AJ, Aihara M, Khawaja AP, Lin SC, et al
   Clinical implications of lowering episcleral venous pressure in the management of glaucoma and the use of Rho kinase inhibitors.
   Surv Ophthalmol. 2025 Mar 17:S0039-6257(25)00052.
   PubMed     Abstract available
   
   
   
9. GHALEB R, Sallam AB, Grigorian F, Phillips PH, et al
   Oral fluorescein angiography in pediatric ophthalmology.
   Surv Ophthalmol. 2025 Mar 13:S0039-6257(25)00051.
   PubMed     Abstract available
   
   
   
10. CHEN Y, Jiang F, Zeng Y, Zhang M, et al
    The role of retinal pigment epithelial senescence and the potential of senotherapeutics in age-related macular degeneration.
    Surv Ophthalmol. 2025 Mar 13:S0039-6257(25)00053.
    PubMed     Abstract available
    
    
    
11. YAO A, Hussain A, Kannan R, Nduka C, et al
    Dynamic procedures for eyelid involvement in facial nerve palsy.
    Surv Ophthalmol. 2025 Mar 13:S0039-6257(25)00054.
    PubMed     Abstract available
    
    
    
12. RODRIGUEZ-GARCIA A, Ruiz-Lozano RE, Barcelo-Canton RH, Marines-Sanchez HM, et al
    The Etiologic and Pathogenic Spectrum of Exposure Keratopathy: Diagnostic and Therapeutic Implications.
    Surv Ophthalmol. 2025 Mar 8:S0039-6257(25)00050.
    PubMed     Abstract available
    
    
    
13. RICKELS KL, Ghaleb R, Elhusseiny AM, Chauhan MZ, et al
    Ocular manifestations secondary to cocaine abuse.
    Surv Ophthalmol. 2025 Mar 5:S0039-6257(25)00032.
    PubMed     Abstract available
    
    
    
14. NEFFENDORF JE, Jackson TL
    Presumed phototoxicity from macular vital staining with Brilliant Blue G and Trypan Blue: A post-market surveillance study, systematic review, and synthesis of the literature.
    Surv Ophthalmol. 2025;70:339-351.
    PubMed     Abstract available
    
    
    
15. LEI Y, Wang Y, Tang S, Yang J, et al
    The adaptive immune system in the retina of diabetics.
    Surv Ophthalmol. 2025;70:241-254.
    PubMed     Abstract available
    
    
    
16. BHATTI MT, Fors DH, Muminovic I, Robbins SL, et al
    Heavy duty.
    Surv Ophthalmol. 2025;70:352-355.
    PubMed     Abstract available
    
    
    
17. ZHANG Q, Wang S, Wang X, Xu C, et al
    Advancing Ophthalmology With Large Language Models: Applications, Challenges, and Future Directions.
    Surv Ophthalmol. 2025 Mar 1:S0039-6257(25)00037.
    PubMed     Abstract available
    
    
    February 2025
18. DUNNIGAN JK, Wang CY, George L, Lee VA, et al
    Social Media in Ophthalmology: A Comprehensive Literature Review.
    Surv Ophthalmol. 2025 Feb 22:S0039-6257(25)00031.
    PubMed     Abstract available
    
    
    
19. GHAFARIAN S, Samavat B, Lee K, Sheikhghomi S, et al
    Clinical strategies to prevent recurrence of Herpes simplex and Herpes zoster following ocular surgery: A comprehensive review with practical guidelines.
    Surv Ophthalmol. 2025 Feb 15:S0039-6257(25)00029.
    PubMed     Abstract available
    
    
    
20. AL-DABET S, Turaev S, Zaki N
    Ocular-Induced Abnormal Head Postures: A Systematic Review and Analysis.
    Surv Ophthalmol. 2025 Feb 9:S0039-6257(25)00021.
    PubMed     Abstract available
    
    
    
21. ZHANG C, Lai D, Zhu D, Palka C, et al
    Chlorhexidine for ocular antisepsis before intravitreal injection: A systematic review and meta-analysis.
    Surv Ophthalmol. 2025 Feb 6:S0039-6257(25)00024.
    PubMed     Abstract available
    
    
    
22. CIFUENTES-GONZALEZ C, Le Tong Y, Mejia-Salgado G, Chan R, et al
    Global demographic and etiological variations of retinal vasculitis: A systematic review and meta-analysis: International Uveitis Study Group (IUSG) Retinal Vasculitis Study (ReViSe) Report 1.
    Surv Ophthalmol. 2025 Feb 5:S0039-6257(25)00023.
    PubMed     Abstract available
    
    
    January 2025
23. YANG Z, Tian D, Xie Z, Cheng T, et al
    Clinical features, diagnosis, management, and prognosis of circumscribed choroidal hemangioma.
    Surv Ophthalmol. 2025 Jan 23:S0039-6257(25)00011.
    PubMed     Abstract available
    
    
    
24. SADEGHI E, Rahmanipour E, Valsecchi N, Kapoor S, et al
    An update on ocular effects of antidiabetic medications.
    Surv Ophthalmol. 2025 Jan 22:S0039-6257(25)00019.
    PubMed     Abstract available
    
    
    
25. TURCAS C, Nicoara SD
    A comprehensive review of structure-function correlations in age-related macular degeneration: Contributions of microperimetry.
    Surv Ophthalmol. 2025 Jan 17:S0039-6257(25)00017.
    PubMed     Abstract available
    
    
    
26. ORTIZ-MORALES G, Ruiz-Lozano RE, Morales-Mancillas N, Homar Paez-Garza J, et al
    Pediatric blepharokeratoconjunctivitis: A challenging ocular surface disease.
    Surv Ophthalmol. 2025 Jan 17:S0039-6257(25)00009.
    PubMed     Abstract available
    
    
    
27. BAYAT K, Pooyan P, Looha MA, Namakin K, et al
    Retinal structural alterations in patients with epilepsy taking antiepileptic drugs: A systematic review and meta-analysis of OCT findings.
    Surv Ophthalmol. 2025 Jan 15:S0039-6257(25)00012.
    PubMed     Abstract available
    
    
    
28. FORTE P, Paques M, Cattaneo J, Dupas B, et al
    Perifoveal vascular anomalous complex and telangiectatic capillaries: An overview of two entities potentially sharing a common pathophysiology.
    Surv Ophthalmol. 2025 Jan 15:S0039-6257(25)00014.
    PubMed     Abstract available
    
    
    
29. FEO A, Stradiotto E, Govetto A, Forte P, et al
    Bacillary layer detachment: Updates on its clinical and prognostic significance in retinal disease.
    Surv Ophthalmol. 2025 Jan 14:S0039-6257(25)00013.
    PubMed     Abstract available
    
    
    
30. DE LOTT LB, Kaplan C, Harte S, Clauw DJ, et al
    Nociplastic pain among individuals with chronic ocular surface pain: one cause for "pain without stain"?
    Surv Ophthalmol. 2025 Jan 13:S0039-6257(25)00015.
    PubMed     Abstract available
    
    
    
31. LIU T, Elnahry AG, Tauqeer Z, Yu Y, et al
    Incidence and risk factors of perioperative suprachoroidal hemorrhage: A systematic review and meta-analysis.
    Surv Ophthalmol. 2025;70:54-62.
    PubMed     Abstract available
    
    
    
32. YANG W, Ren R, Xie Y, Wang J, et al
    Diabetic uveopathy.
    Surv Ophthalmol. 2025;70:47-53.
    PubMed     Abstract available
    
    
    
33. BHATTI MT, Long JR, Carey AR
    Denial.
    Surv Ophthalmol. 2025;70:162-166.
    PubMed     Abstract available
    
    
    December 2024
34. LIN TH, Lin HY, Tseng PC
    Enhancing anti-vascular endothelial growth factor with photodynamic therapy for polypoidal choroidal vasculopathy: A meta-analysis.
    Surv Ophthalmol. 2024 Dec 19:S0039-6257(24)00157.
    PubMed     Abstract available
    
    
    
35. NGOC VAN ANH L, Ngoc Cong N, Ngamjit K, Usanee R, et al
    Penetrating keratoplasty versus deep anteriror lamellar keratoplasty for macular corneal dystrophy: A meta-analysis.
    Surv Ophthalmol. 2024 Dec 19:S0039-6257(24)00156.
    PubMed     Abstract available
    
    
    
36. SERVILLO A, Scandale P, Oldoni G, Begar PG, et al
    Inflammatory choroidal neovascularization: An evidence-based update.
    Surv Ophthalmol. 2024 Dec 18:S0039-6257(24)00155.
    PubMed     Abstract available
    
    
    
37. JIRAVARNSIRIKUL A, Belghith A, Rezapour J, Bowd C, et al
    Evaluating glaucoma in myopic eyes: Challenges and opportunities.
    Surv Ophthalmol. 2024 Dec 17:S0039-6257(24)00154.
    PubMed     Abstract available
    
    
    
38. SANTINA A, Feo A, Bousquet E, Velaga SB, et al
    Pentosan polysulfate sodium maculopathy: Final analysis of a prospective cohort, updated review, and association with inflammatory bowel disease.
    Surv Ophthalmol. 2024 Dec 12:S0039-6257(24)00153.
    PubMed     Abstract available
    
    
    
39. NAGINO K, Inomata T, Ohta T, Sung J, et al
    Postoperative complications of intrascleral intraocular lens fixation: A systematic review and meta-analysis.
    Surv Ophthalmol. 2024 Dec 12:S0039-6257(24)00152.
    PubMed     Abstract available
    
    
    November 2024
40. EIJGEN JV, Winckel LV, Hanssen H, Kotliar K, et al
    Retinal vessel analysis to assess microvascular function in the healthy eye: A systematic review on the response to acute physiological and pathological stressors.
    Surv Ophthalmol. 2024 Nov 24:S0039-6257(24)00140.
    PubMed     Abstract available
    
    
    
41. RAI BB, Maddess T, Nolan CJ
    Functional diabetic retinopathy: A new concept to improve management of diabetic retinal diseases.
    Surv Ophthalmol. 2024 Nov 23:S0039-6257(24)00142.
    PubMed     Abstract available
    
    
    
42. ISSA M, Sukkarieh G, Gallardo M, Sarbout I, et al
    Applications of artificial intelligence to inherited retinal diseases: A systematic review.
    Surv Ophthalmol. 2024 Nov 18:S0039-6257(24)00139.
    PubMed     Abstract available
    
    
    
43. LEE SJV, FRCOphth, Goh YQ, Rojas-Carabali W, et al
    Association between retinal vessels caliber and systemic health: A comprehensive review.
    Surv Ophthalmol. 2024 Nov 16:S0039-6257(24)00138.
    PubMed     Abstract available
    
    
    
44. VAHEB S, Panah MY, Shaygannejad V, Zabeti A, et al
    Uveitis among people with multiple sclerosis: A systematic review and meta-analysis.
    Surv Ophthalmol. 2024 Nov 15:S0039-6257(24)00134.
    PubMed     Abstract available
    
    
    
45. PUTERA I, Distia Nora R, Dewi AC, Suhada DS, et al
    Antiviral therapy for cytomegalovirus retinitis: A systematic review and meta-analysis.
    Surv Ophthalmol. 2024 Nov 14:S0039-6257(24)00141.
    PubMed     Abstract available
    
    
    
46. RIZZO C, Savastano MC, Kilian R, Marchini G, et al
    Structural en face optical coherence tomography in neovascular and nonneovascularage-related macular degeneration: Use and utility in clinical practice.
    Surv Ophthalmol. 2024 Nov 8:S0039-6257(24)00135.
    PubMed     Abstract available
    
    
    
47. LI L, Xiao K, Shang X, Hu W, et al
    Advances in artificial intelligence for meibomian gland evaluation: A comprehensive review.
    Surv Ophthalmol. 2024;69:945-956.
    PubMed     Abstract available
    
    
    October 2024
48. ELSAYED MEA, Lander B, Senthil S, Edward DP, et al
    The Secondary Childhood Glaucomas.
    Surv Ophthalmol. 2024 Oct 30:S0039-6257(24)00132.
    PubMed     Abstract available
    
    
    
49. SADEGHI E, Valsecchi N, Rahmanipour E, Ejlalidiz M, et al
    Choroidal biomarkers in age-related macular degeneration.
    Surv Ophthalmol. 2024 Oct 17:S0039-6257(24)00131.
    PubMed     Abstract available
    
    
    
50. ALBRECHT M, Auffarth GU, Friedrich M, Kessler LJ, et al
    Vision degrading myodesopsia from vitreous floaters in the young: An important aspect of myopia.
    Surv Ophthalmol. 2024 Oct 16:S0039-6257(24)00128.
    PubMed     Abstract available
    
    
    
51. NEWMAN NJ, Biousse V, Yu-Wai-Man P, Carelli V, et al
    Meta-analysis of treatment outcomes for patients with m.11778G>A MT-ND4 Leber Hereditary Optic Neuropathy.
    Surv Ophthalmol. 2024 Oct 15:S0039-6257(24)00130.
    PubMed     Abstract available
    
    
    
52. GUPTA Y, Devi C, Priyadarshini K, Mandal S, et al
    Pediatric Keratoconus.
    Surv Ophthalmol. 2024 Oct 11:S0039-6257(24)00129.
    PubMed     Abstract available
    
    
    
53. HOVEN E, Michelet JT, Vettore MV, Lagali N, et al
    Choroidal thickness after anti-VEGF in typical neovascular age-related macular degeneration - A systematic review and meta-analysis.
    Surv Ophthalmol. 2024 Oct 5:S0039-6257(24)00124.
    PubMed     Abstract available
    
    
    September 2024
54. MIKHAIL D, Milad D, Antaki F, Hammamji K, et al
    The role of artificial intelligence in macular hole management: A scoping review.
    Surv Ophthalmol. 2024 Sep 30:S0039-6257(24)00123.
    PubMed     Abstract available
    
    
    
55. BERMAN G, Pendley AM, Wright DW, Silverman R, et al
    Breaking the barriers: Methodology of implementation of a non-mydriatic ocular fundus camera in an emergency department.
    Surv Ophthalmol. 2024 Sep 30:S0039-6257(24)00127.
    PubMed     Abstract available
    
    
    
56. TAN JCK, Yohannan J, Ramulu PY, Kalloniatis M, et al
    Visual field testing in glaucoma using the Swedish Interactive Threshold Algorithm.
    Surv Ophthalmol. 2024 Sep 28:S0039-6257(24)00118.
    PubMed     Abstract available
    
    
    
57. STALHAMMAR G, Hagstrom A, Ermedahl Conradi M, Williams PA, et al
    Choroidal nevi and melanoma doubling times and implications for delays in treatment: A systematic review and meta-analysis.
    Surv Ophthalmol. 2024 Sep 28:S0039-6257(24)00117.
    PubMed     Abstract available
    
    
    
58. ALISI L, Giovannetti F, Armentano M, Lucchino L, et al
    Challenging corneal diseases and miRNA expression: Focus on rare diseases and new therapeutic frontiers.
    Surv Ophthalmol. 2024 Sep 27:S0039-6257(24)00120.
    PubMed     Abstract available
    
    
    
59. FERRO DESIDERI L, Sim PY, Bernardi E, Paschon K, et al
    Evidence-based guidelines for drug dosing in intravitreal injections in silicone oil-filled eyes: Pharmacokinetics, safety, and optimal dosage.
    Surv Ophthalmol. 2024 Sep 27:S0039-6257(24)00119.
    PubMed     Abstract available
    
    
    
60. D'ALBENZIO A, Komici K, Affatato M, Castelluzzo AM, et al
    Vitreous Cortex Remnants in Patients With Rhegmatogenous Retinal Detachment: A Systematic Review and Meta-analysis.
    Surv Ophthalmol. 2024 Sep 26:S0039-6257(24)00121.
    PubMed     Abstract available
    
    
    
61. LEI C, Lv Z, Hua R, Duan J, et al
    Focal choroidal excavation: Review and updated pathogenesis.
    Surv Ophthalmol. 2024 Sep 25:S0039-6257(24)00126.
    PubMed     Abstract available
    
    
    
62. YANG Q, Ju G, He Y
    Corneal densitometry: New evaluation indicator for corneal diseases.
    Surv Ophthalmol. 2024 Sep 24:S0039-6257(24)00122.
    PubMed     Abstract available
    
    
    
63. WANG K, Liu Y, Li S, Zhao N, et al
    Unveiling the therapeutic potential and mechanisms of stanniocalcin-1 in retinal degeneration.
    Surv Ophthalmol. 2024 Sep 11:S0039-6257(24)00085.
    PubMed     Abstract available
    
    
    
64. SUH A, Ditelberg S, Szeto JJ, Kumar D, et al
    Safety protocols, precautions, and countermeasures aboard the International Space Station (ISS) to prevent ocular injury.
    Surv Ophthalmol. 2024 Sep 3:S0039-6257(24)00097.
    PubMed     Abstract available
    
    
    
65. L'ABBATE D, Prescott K, Geraghty B, Kearns VR, et al
    Biomechanical considerations for optimising subretinal injections.
    Surv Ophthalmol. 2024;69:722-732.
    PubMed     Abstract available
    
    
    
66. TAWFIK HA, Ali MJ
    A major review on punctal stenosis: Part II: Updated therapeutic interventions, complications, and outcomes.
    Surv Ophthalmol. 2024;69:756-768.
    PubMed     Abstract available
    
    
    
67. BIRCH EE, Duffy KR
    Leveraging neural plasticity for the treatment of amblyopia.
    Surv Ophthalmol. 2024;69:818-832.
    PubMed     Abstract available
    
    
    
68. CHEN JS, Korn BS, Carey AR, Savino PJ, et al
    Looking beyond blurred margins.
    Surv Ophthalmol. 2024;69:842-846.
    PubMed     Abstract available
    
    
    August 2024
69. CHAUHAN K, Dave VP, de Ribot FM, Agrawal R, et al
    Traumatic retinal detachment: A contemporary update.
    Surv Ophthalmol. 2024 Aug 31:S0039-6257(24)00101.
    PubMed     Abstract available
    
    
    
70. MANO F, LoBue S, Tailor P, Olsen TW, et al
    Incisional choroidal surgery.
    Surv Ophthalmol. 2024 Aug 31:S0039-6257(24)00096.
    PubMed     Abstract available
    
    
    
71. JESSUP AJC, Coroneo MT
    Examining the fabric of the eye: Antoni van Leeuwenhoek, the draper and ocular microscopist.
    Surv Ophthalmol. 2024 Aug 28:S0039-6257(24)00098.
    PubMed     Abstract available
    
    
    
72. ZHAO Q, Wei L, Chen Y
    Detection of choroidal vascular features in diabetic patients without clinically visible diabetic retinopathy by optical coherence tomography angiography: A systemic review and meta-analysis.
    Surv Ophthalmol. 2024 Aug 28:S0039-6257(24)00100.
    PubMed     Abstract available
    
    
    
73. SURICO PL, Barone V, Singh RB, Coassin M, et al
    Potential applications of mesenchymal stem cells in ocular surface immune-mediated disorders.
    Surv Ophthalmol. 2024 Aug 1:S0039-6257(24)00083.
    PubMed     Abstract available
    
    
    
74. SCHLOESSER L, Klose SM, Mauschitz MM, Abdullah Z, et al
    The role of immune modulators in age-related macular degeneration.
    Surv Ophthalmol. 2024 Aug 1:S0039-6257(24)00084.
    PubMed     Abstract available
    
    
    July 2024
75. MARMOR MF
    Lupus review is misleading about risk of hydroxychloroquine retinal toxicity.
    Surv Ophthalmol. 2024 Jul 24:S0039-6257(24)00082.
    PubMed    
    
    
    
76. ZHANG Z, Shan X, Li S, Chang J, et al
    Retinal light damage: From mechanisms to protective strategies.
    Surv Ophthalmol. 2024 Jul 23:S0039-6257(24)00079.
    PubMed     Abstract available
    
    
    
77. VUJOSEVIC S, Lupidi M, Donati S, Astarita C, et al
    Role of inflammation in diabetic macular edema and neovascular age-related macular degeneration.
    Surv Ophthalmol. 2024 Jul 17:S0039-6257(24)00080.
    PubMed     Abstract available
    
    
    
78. FOUAD YA, Cicinelli MV, Marchese A, Casalino G, et al
    Revisiting acute retinal pigment epitheliitis (Krill disease).
    Surv Ophthalmol. 2024 Jul 16:S0039-6257(24)00078.
    PubMed     Abstract available
    
    
    
79. TORKASHVAND A, Izadian A, Hajrasouliha A
    Advances in Ophthalmic Therapeutic Delivery: A Comprehensive Overview of Present and Future Directions.
    Surv Ophthalmol. 2024 Jul 8:S0039-6257(24)00076.
    PubMed     Abstract available
    
    
    
80. HASHEMI E, Looha MA, Mazaherinia H, Samadaeian N, et al
    Risk of stroke development following retinal vein occlusion: A systematic review and meta-analysis.
    Surv Ophthalmol. 2024 Jul 3:S0039-6257(24)00074.
    PubMed     Abstract available
    
    
    
81. SINCLAIR SH, Schwartz S
    Diabetic retinopathy: New concepts of screening, monitoring, and interventions.
    Surv Ophthalmol. 2024 Jul 2:S0039-6257(24)00077.
    PubMed     Abstract available
    
    
    
82. WU H, Jin K, Yip CC, Koh V, et al
    A systematic review of economic evaluation of artificial intelligence-based screening for eye diseases: From possibility to reality.
    Surv Ophthalmol. 2024;69:499-507.
    PubMed     Abstract available
    
    
    
83. BUNJO LJ, Bacchi S, Pietris J, Chan WO, et al
    Current management options for the treatment of refractory postoperative cystoid macular edema: A systematic review.
    Surv Ophthalmol. 2024;69:606-621.
    PubMed     Abstract available
    
    
    
84. LEIDY L, Dickinson A, Ramulu P, Ehrlich J, et al
    Clinical outcome measures in vision and eye care.
    Surv Ophthalmol. 2024;69:632-637.
    PubMed     Abstract available
    
    
    June 2024
85. HOSSEINI F, Asadi F, Rabiei R, Kiani F, et al
    Applications of artificial intelligence in diagnosis of uncommon cystoid macular edema using optical coherence tomography imaging: A systematic review.
    Surv Ophthalmol. 2024 Jun 26:S0039-6257(24)00073.
    PubMed     Abstract available
    
    
    
86. PARRAVANO M, Cennamo G, Di Antonio L, Grassi MO, et al
    Multimodal imaging in diabetic retinopathy and macular edema: An update about biomarkers.
    Surv Ophthalmol. 2024 Jun 26:S0039-6257(24)00075.
    PubMed     Abstract available
    
    
    
87. DAUNGSUPAWONG H, Wiwanitkit V
    Generative artificial intelligence in ophthalmology: Correspondence.
    Surv Ophthalmol. 2024 Jun 17:S0039-6257(24)00071.
    PubMed    
    
    
    
88. FARAHAT Z, Zrira N, Souissi N, Bennani Y, et al
    Diabetic retinopathy screening through artificial intelligence algorithms: A systematic review.
    Surv Ophthalmol. 2024 Jun 15:S0039-6257(24)00051.
    PubMed     Abstract available
    
    
    
89. POSARELLI M, Passaro ML, Avolio FC, Costagliola C, et al
    The incidence of severe complications in acanthamoeba keratitis: Qualitative and quantitative systematic assessment.
    Surv Ophthalmol. 2024 Jun 15:S0039-6257(24)00069.
    PubMed     Abstract available
    
    
    
90. WAISBERG E, Ong J, Masalkhi M, Lee AG, et al
    Future directions of generative artificial intelligence in ophthalmology and vision science.
    Surv Ophthalmol. 2024 Jun 14:S0039-6257(24)00072.
    PubMed    
    
    
    May 2024
91. BACHMEIER I, Armendariz BG, Yu S, Jager RJ, et al
    Corrigendum to "Fibrosis in neovascular age-related macular degeneration: a review of definitions based on clinical imaging" [Surv Ophthalmol 68 (2023) 835-848/5].
    Surv Ophthalmol. 2024 May 28:S0039-6257(23)00137.
    PubMed    
    
    
    
92. HERNANDEZ RF, Rodriguez JEM, Trecu MS, Tariq Bhatti M, et al
    Not everything is ischemic optic neuropathy.
    Surv Ophthalmol. 2024 May 23:S0039-6257(24)00054.
    PubMed     Abstract available
    
    
    
93. VEMPULURU VS, Maniar A, Bakal K, Kaliki S, et al
    Role of MYCN in Retinoblastoma: A Review of Current Literature.
    Surv Ophthalmol. 2024 May 23:S0039-6257(24)00055.
    PubMed     Abstract available
    
    
    
94. CHENG T, Gu X, Yang Z, Wang C, et al
    Clinical features of ocular damage in systemic lupus erythematosus and risk factors of hydroxychloroquine related complications.
    Surv Ophthalmol. 2024 May 21:S0039-6257(24)00052.
    PubMed     Abstract available
    
    
    
95. KNECHT KT, Chiriac G, Guan HD
    The potential impact of a vegetarian diet on glaucoma.
    Surv Ophthalmol. 2024 May 18:S0039-6257(24)00048.
    PubMed     Abstract available
    
    
    
96. WAISBERG E, Ong J, Kamran SA, Masalkhi M, et al
    Generative artificial intelligence in ophthalmology.
    Surv Ophthalmol. 2024 May 16:S0039-6257(24)00044.
    PubMed     Abstract available
    
    
    
97. FEKRAZAD S, Hassanzadeh G, Salehi MA, Mozafar M, et al
    Optical coherence tomography angiography measurements in systemic lupus erythematosus: A systematic review and meta-analysis.
    Surv Ophthalmol. 2024 May 12:S0039-6257(24)00047.
    PubMed     Abstract available
    
    
    
98. TRINCAO-MARQUES TM, Ayton LN, Hickey DG, Marques-Neves C, et al
    Gene and cell therapy for age-related macular degeneration: A review.
    Surv Ophthalmol. 2024 May 10:S0039-6257(24)00049.
    PubMed     Abstract available
    
    
    
99. NIAZI S, Doroodgar F, Nazari SH, Rahimi Y, et al
    Refractive surgical approaches to keratoconus: A systematic review and network meta-analysis.
    Surv Ophthalmol. 2024 May 4:S0039-6257(24)00045.
    PubMed     Abstract available
    
    
    
100. TAWFIK HA, Ali MJ
     A major review of punctal stenosis: Updated anatomy, epidemiology, etiology, and clinical presentation.
     Surv Ophthalmol. 2024;69:441-455.
     PubMed     Abstract available
     
     
     
101. HUANG RS, Mihalache A, Popovic MM, Cruz-Pimentel M, et al
     Diagnostic methods for primary vitreoretinal lymphoma: A systematic review.
     Surv Ophthalmol. 2024;69:456-464.
     PubMed     Abstract available
     
     
     
102. ROY R, Chattree S, Kala U, Majumdar B, et al
     Multicolor imaging: Current clinical applications.
     Surv Ophthalmol. 2024;69:378-402.
     PubMed     Abstract available
     
     
     
103. ARORA S, Zur D, Iovino C, Chhablani J, et al
     Peripapillary fluid: Obvious and not so obvious!
     Surv Ophthalmol. 2024;69:311-329.
     PubMed     Abstract available
     
     
     
104. PELLEGRINI F, Basciu M, Foroozan R
     Planet of the apex.
     Surv Ophthalmol. 2024;69:495-498.
     PubMed     Abstract available
     
     
     April 2024
105. VERA-DUARTE GR, Jimenez-Collado D, Kahuam-Lopez N, Ramirez-Miranda A, et al
     Neurotrophic keratopathy: General features and new therapies.
     Surv Ophthalmol. 2024 Apr 26:S0039-6257(24)00042.
     PubMed     Abstract available
     
     
     
106. LEE YM, Bahrami B, Selva D, Casson RJ, et al
     Scoping review of non-surgical treatment options for macular holes.
     Surv Ophthalmol. 2024 Apr 25:S0039-6257(24)00043.
     PubMed     Abstract available
     
     
     
107. KANG C, Lee MJ, Chomsky A, Oetting TA, et al
     Risk factors for complications in resident-performed cataract surgery: A systematic review.
     Surv Ophthalmol. 2024 Apr 20:S0039-6257(24)00032.
     PubMed     Abstract available
     
     
     
108. SALEHI MA, Frounchi N, Zakavi SS, Mohammadi S, et al
     Retinal and choroidal changes after anti-VEGF therapy in Neovascular-AMD Patients: A Systematic Review and Meta-Analysis of SD-OCT studies.
     Surv Ophthalmol. 2024 Apr 17:S0039-6257(24)00033.
     PubMed     Abstract available
     
     
     
109. KROLO I, Behaegel J, Termote K, de Bruyn B, et al
     The role of topical insulin on ocular surface restoration: A review.
     Surv Ophthalmol. 2024 Apr 10:S0039-6257(24)00031.
     PubMed     Abstract available
     
     
     March 2024
110. ARDA H, Maier M, Schultheiss M, Haritoglou C, et al
     Advances in management strategies for large and persistent macular hole: an update.
     Surv Ophthalmol. 2024 Mar 27:S0039-6257(24)00030.
     PubMed     Abstract available
     
     
     
111. NOURI H, Abtahi SH, Mazloumi M, Samadikhadem S, et al
     Optical coherence tomography angiography in diabetic retinopathy: A major review.
     Surv Ophthalmol. 2024 Mar 21:S0039-6257(24)00021.
     PubMed     Abstract available
     
     
     
112. BRESSLER NM, Kaiser PK, Do DV, Nguyen QD, et al
     Biosimilars of anti-vascular endothelial growth factor for ophthalmic diseases: A review.
     Surv Ophthalmol. 2024 Mar 21:S0039-6257(24)00029.
     PubMed     Abstract available
     
     
     
113. SCHEFFER M, Menting J, Boeije H, van Nispen R, et al
     Understanding healthcare communication in age-related macular degeneration care: A mixed-methods review of patients' perspectives.
     Surv Ophthalmol. 2024 Mar 16:S0039-6257(24)00018.
     PubMed     Abstract available
     
     
     
114. SABATINO F, Banerjee P, K Muqit MM
     Clinical therapeutics for proliferative vitreoretinopathy in retinal detachment.
     Surv Ophthalmol. 2024 Mar 15:S0039-6257(24)00024.
     PubMed     Abstract available
     
     
     
115. ANG T, Chaggar V, Tong JY, Selva D, et al
     Medication-associated orbital inflammation: A systematic review.
     Surv Ophthalmol. 2024 Mar 13:S0039-6257(24)00020.
     PubMed     Abstract available
     
     
     
116. ORTIZ-SELLER A, Martorell P, Barranco H, Pascual-Camps I, et al
     Comparison of different agents and doses of anti-vascular endothelial growth factors (aflibercept, bevacizumab, conbercept, ranibizumab) versus laser for retinopathy of prematurity: A network meta-analysis.
     Surv Ophthalmol. 2024 Mar 1:S0039-6257(24)00008.
     PubMed     Abstract available
     
     
     
117. OO HH, Mohan M, Song W, Rojas-Carabali W, et al
     Anterior chamber inflammation grading methods: A critical review.
     Surv Ophthalmol. 2024;69:253-264.
     PubMed     Abstract available
     
     
     
118. YESILTAS YS, Oakey Z, Wrenn J, Yeaney G, et al
     Uveal melanoma in African Americans: Diagnostic challenges.
     Surv Ophthalmol. 2024;69:190-197.
     PubMed     Abstract available
     
     
     
119. ARNOLD RW
     Surgical and anesthetic influences of the oculocardiac reflex in adults and children during strabismus surgery.
     Surv Ophthalmol. 2024;69:295.
     PubMed    
     
     
     
120. ROBBINS SL, Greenberg M, Juan I
     Surgical and anesthetic influences of the oculocardiac reflex in adults and children during strabismus surgery.
     Surv Ophthalmol. 2024;69:S0039-625700087-5.
     PubMed    
     
     
     February 2024
121. JIANG F, Lei C, Chen Y, Zhou N, et al
     The complement system and diabetic retinopathy.
     Surv Ophthalmol. 2024 Feb 23:S0039-6257(24)00007.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Ophthalmology is free of charge.